PharOS

PharOS, a privately held pharmaceutical firm, is engaged in the development, production, and distribution of Generic, Over the Counter, and Value-Added Medicines. The company boasts a global portfolio of over 89 products and holds more than 7,905 marketing authorizations in excess of 105 countries worldwide. Additionally, PharOS offers value added services in Contract Manufacturing, Product Development, and Regulatory Affairs.